| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 41 |
| 1 | SILDENAFIL CITRATE | 31 |
| 2 | ASPIRIN | 28 |
| 3 | FUROSEMIDE | 26 |
| 4 | ASPIRIN 325 MG | 25 |
| 5 | ASPIRIN 81 MG | 25 |
| 6 | POTASSIUM CHLORIDE | 25 |
| 7 | BOSENTAN | 20 |
| 8 | POTASSIUM CHLORIDE EXTENDED-RELEASE | 20 |
| 9 | POTASSIUM CHLORIDE ORAL | 20 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TAFASITAMAB-CXIX | 6 | 0.0066 |
| 1 | GLOFITAMAB | 7 | 0.0026 |
| 2 | FOSINOPIRL SODIUM | 3 | 0.0014 |
| 3 | SOTATERCEPT-CSRK | 8 | 0.0013 |
| 4 | SCOPOLAMINE | 4 | 0.0011 |
| 5 | CLOFAZIMINE | 6 | 0.0009 |
| 6 | FOSINOPRIL | 3 | 0.0007 |
| 7 | ERGOCALCIFEROL | 18 | 0.0006 |
| 8 | CLINDAMYCIN PHOSPHATE | 3 | 0.0005 |
| 9 | EPOPROSTENOL | 7 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 45 |
| 1 | Loop Diuretic [EPC] | 42 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 38 |
| 3 | Corticosteroid [EPC] | 37 |
| 4 | Endothelin Receptor Antagonist [EPC] | 33 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 28 |
| 6 | Osmotic Laxative [EPC] | 26 |
| 7 | Phosphodiesterase 5 Inhibitor [EPC] | 26 |
| 8 | Potassium Salt [EPC] | 20 |
| 9 | Provitamin D2 Compound [EPC] | 18 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 7 | 0.0017 |
| 1 | Provitamin D2 Compound [EPC] | 18 | 0.0006 |
| 2 | Soluble Guanylate Cyclase Stimulator [EPC] | 12 | 0.0004 |
| 3 | Prostacycline Vasodilator [EPC] | 45 | 0.0003 |
| 4 | Calcitonin [EPC] | 1 | 0.0003 |
| 5 | Antimycobacterial [EPC] | 7 | 0.0003 |
| 6 | Anticholinergic [EPC] | 4 | 0.0002 |
| 7 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 8 | Antiseptic [EPC] | 1 | 0.0002 |
| 9 | Cardiac Glycoside [EPC] | 15 | 0.0002 |